Internal Medicine, Infectious Disease · New York, NY
NPI
1174784318
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
622 W 168th St
New York, NY, 10032
Phone (212) 305-9369
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
409 services
Medicare patients, 2024
164
Average age 71
Drug cost, 2024
$676K
841 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin A Miko was code 99233 (hospital e&m - subsequent), 228 times for 81 patients. In total Benjamin A Miko billed 409 services in 17 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 228 | 81 | $109.90 | $25K |
| 99223 Hospital E&M - Initial | Facility | 74 | 73 | $159.28 | $12K |
| 99215 Office E&M - Established | Office | 43 | 27 | $139.98 | $6,019 |
| 99205 Office E&M - New | Office | 15 | 15 | $183.60 | $2,754 |
By year: 2022 $58K for 510 services; 2023 $34K for 285 services; 2024 $48K for 409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin A Miko prescribed most often to Medicare patients was Atorvastatin Calcium, with 36 prescriptions and refills. In total Benjamin A Miko wrote 841 Medicare prescriptions that cost $676K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 36 | 76 | Under 11 | $389 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 35 | 37 | Under 11 | $148K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 34 | 40 | Under 11 | $146K |
| Lisinopril Generic | 27 | 31 | Under 11 | $76.14 |
| Amlodipine Besylate Generic | 25 | 29 | Under 11 | $93.51 |
| Dovato Dolutegravir Sodium/Lamivudine | 24 | 24 | Under 11 | $71K |
| Jardiance Empagliflozin | 23 | 31 | Under 11 | $17K |
| Escitalopram Oxalate Generic | 23 | 43 | Under 11 | $113 |
| Furosemide Generic | 21 | 25 | Under 11 | $72.3 |
| Allopurinol Generic | 21 | 21 | Under 11 | $67.59 |
| Posaconazole Generic | 21 | 21 | Under 11 | $16K |
| Nevirapine Generic | 17 | 25 | Under 11 | $3,279 |
| Finasteride Generic | 17 | 23 | Under 11 | $65.64 |
| Acyclovir Generic | 16 | 18 | Under 11 | $176 |
| Rosuvastatin Calcium Generic | 14 | 18 | Under 11 | $46.44 |
Brand drugs: - claims; generic drugs: 606 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Benjamin A Miko were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.